TriGemX Bio focuses on developing innovative medicines for migraine treatment by leveraging unique insights into neural signaling pathways. The company serves patients seeking effective solutions for migraine relief.
Founded
2006
Total Funding
Tens of millions
Total Rounds
1
First Raise
Oct 1, 2026
Latest Raise
Oct 1, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/1/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free